发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| USA | 113 |
| Italy | 41 |
| England | 34 |
| GERMANY (FED REP GER) | 28 |
| Canada | 24 |
| Australia | 23 |
| Netherlands | 19 |
| Switzerland | 17 |
| New Zealand | 16 |
| CHINA MAINLAND | 13 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| UNIVERSITY OF LONDON | 15 |
| SAPIENZA UNIVERSITY ROME | 13 |
| BIOGEN | 9 |
| SPRINGER NATURE | 9 |
| HARVARD UNIVERSITY | 8 |
| UNIVERSITY OF SYDNEY | 8 |
| UNIVERSITY OF TORONTO | 8 |
| PARACELSUS PRIVATE MEDICAL UNIVERSITY | 7 |
| UNIVERSITY OF CALIFORNIA SYSTEM | 7 |
| UNIVERSITY OF MELBOURNE | 7 |
文章引用情况
1
The Safety of Second-Generation Antipsychotics During Pregnancy: A Clinically Focused Review2
Risk of Intracranial Hemorrhage Associated with the Use of Antidepressants Inhibiting Serotonin Reuptake: A Systematic Review3
Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents4
An Integrated Safety Analysis of Infants and Children with Symptomatic Spinal Muscular Atrophy (SMA) Treated with Nusinersen in Seven Clinical Trials5
Recent Advances in the Drug Treatment of Dravet Syndrome6
Assessment and Management of Neuropsychiatric Symptoms in Parkinson's Disease7
Cannabinoid-Based Therapies and Brain Development: Potential Harmful Effect of Early Modulation of the Endocannabinoid System8
An Update on Vitamin D and Disease Activity in Multiple Sclerosis9
Pharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development10
Novel Treatment Opportunities Against Cognitive Impairment in Parkinson's Disease with an Emphasis on Diabetes-Related Pathways